SF targets the multiple kinase protein B-Raf and C-Raf, Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), and Platelet-derived Growth Factor Receptor (PDGFR), which are responsible for HCC [15,16]. Here, KDR is linked to hepatocellular carcinoma.